Meghmani Organics Ltd(Merged)
Meghmani Organics Ltd (MOL) manufactures green and blue pigment products, which are used to manufacture printing ink, plastic, paints, textiles, leather, and rubber.
It also manufactures a wide variety of commonly used pesticides for crop and non-crop applications, this include insect control in wood preservation and food grain storage. [1]
In 2009, Meghmani Finechem Ltd (MFL), subsidiary of MOL also commissioned its caustic soda plant, which has the capacity of 294,000 tonnes per annum and is powered by a 96-megawatt captive power plant. [2]
- Market Cap ₹ 2,270 Cr.
- Current Price ₹ 138
- High / Low ₹ /
- Stock P/E 9.58
- Book Value ₹ 52.2
- Dividend Yield 0.00 %
- ROCE 19.9 %
- ROE 21.8 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 35.3% CAGR over last 5 years
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
791 | 816 | 1,045 | 1,062 | 1,058 | 1,178 | 1,294 | 1,332 | 1,420 | 1,800 | 2,088 | 2,191 | 2,232 | |
702 | 693 | 896 | 904 | 873 | 983 | 1,075 | 1,063 | 1,131 | 1,365 | 1,540 | 1,756 | 1,720 | |
Operating Profit | 89 | 124 | 149 | 159 | 186 | 196 | 219 | 269 | 288 | 434 | 548 | 436 | 512 |
OPM % | 11% | 15% | 14% | 15% | 18% | 17% | 17% | 20% | 20% | 24% | 26% | 20% | 23% |
2 | 18 | 8 | 12 | 12 | 6 | -10 | 17 | 9 | 26 | 14 | 55 | 42 | |
Interest | 26 | 42 | 54 | 74 | 64 | 68 | 75 | 63 | 51 | 40 | 56 | 43 | 61 |
Depreciation | 17 | 51 | 69 | 75 | 75 | 80 | 75 | 77 | 91 | 95 | 97 | 89 | 112 |
Profit before tax | 48 | 48 | 34 | 23 | 58 | 54 | 60 | 146 | 156 | 326 | 409 | 359 | 381 |
Tax % | 23% | 18% | 13% | 84% | 51% | 34% | 23% | 24% | 25% | 27% | 28% | 20% | |
37 | 40 | 30 | 4 | 28 | 35 | 46 | 111 | 116 | 238 | 295 | 289 | 276 | |
EPS in Rs | 1.46 | 2.03 | 1.49 | 0.14 | 0.68 | 0.90 | 1.73 | 3.24 | 3.45 | 6.74 | 9.88 | 9.44 | 9.48 |
Dividend Payout % | 23% | 20% | 27% | 73% | 15% | 11% | 23% | 9% | 12% | 6% | 10% | 11% |
Compounded Sales Growth | |
---|---|
10 Years: | 10% |
5 Years: | 11% |
3 Years: | 16% |
TTM: | 0% |
Compounded Profit Growth | |
---|---|
10 Years: | 19% |
5 Years: | 35% |
3 Years: | 39% |
TTM: | -11% |
Stock Price CAGR | |
---|---|
10 Years: | 21% |
5 Years: | 23% |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 20% |
3 Years: | 24% |
Last Year: | 22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
Reserves | 403 | 442 | 469 | 451 | 477 | 493 | 526 | 732 | 693 | 845 | 978 | 1,184 |
569 | 639 | 715 | 763 | 717 | 754 | 644 | 578 | 461 | 386 | 716 | 790 | |
264 | 242 | 257 | 246 | 321 | 391 | 346 | 258 | 401 | 555 | 657 | 738 | |
Total Liabilities | 1,261 | 1,349 | 1,466 | 1,485 | 1,540 | 1,663 | 1,542 | 1,594 | 1,580 | 1,811 | 2,376 | 2,737 |
199 | 641 | 654 | 656 | 623 | 689 | 781 | 735 | 778 | 795 | 737 | 926 | |
CWIP | 418 | 44 | 56 | 86 | 165 | 126 | 23 | 92 | 19 | 103 | 518 | 792 |
Investments | 41 | 19 | 36 | 20 | 25 | 1 | 24 | 1 | 29 | 72 | 1 | 1 |
602 | 645 | 720 | 724 | 728 | 848 | 713 | 766 | 754 | 841 | 1,122 | 1,018 | |
Total Assets | 1,261 | 1,349 | 1,466 | 1,485 | 1,540 | 1,663 | 1,542 | 1,594 | 1,580 | 1,811 | 2,376 | 2,737 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
55 | 81 | 126 | 134 | 205 | 136 | 252 | 201 | 259 | 405 | 375 | 404 | |
-313 | -114 | -119 | -75 | -94 | -46 | -59 | -73 | -96 | -274 | -291 | -481 | |
289 | 31 | 9 | -50 | -132 | -60 | -213 | -134 | -164 | -128 | 45 | -48 | |
Net Cash Flow | 30 | -1 | 16 | 8 | -21 | 30 | -19 | -6 | -1 | 2 | 129 | -125 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 131 | 141 | 120 | 114 | 117 | 109 | 89 | 90 | 85 | 76 | 75 | 88 |
Inventory Days | 79 | 94 | 83 | 96 | 107 | 132 | 103 | 161 | 111 | 107 | 145 | 104 |
Days Payable | 65 | 74 | 69 | 62 | 87 | 92 | 68 | 92 | 75 | 78 | 91 | 81 |
Cash Conversion Cycle | 144 | 161 | 135 | 148 | 138 | 149 | 124 | 159 | 121 | 105 | 130 | 111 |
Working Capital Days | 188 | 199 | 173 | 169 | 160 | 163 | 131 | 139 | 126 | 96 | 87 | 80 |
ROCE % | 11% | 8% | 7% | 7% | 10% | 9% | 11% | 17% | 16% | 26% | 29% | 20% |
Documents
Announcements
- Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th August, 2021. 10 Aug 2021
- Board Meeting Intimation for Intimation Of The Board Meeting Of Meghmani Organics Limited (Formerly Known As Meghmani Organochem Limited) ('Company') Scheduled To Be Held On 10Th August, 2021. 3 Aug 2021
- Announcement under Regulation 30 (LODR)-Investor Presentation 3 Jul 2021
-
Announcement under Regulation 30 (LODR)-Investor Presentation
24 May 2021 - Meghmani submits Investor Presentation on the Financials for the quarter and year ended 31st March, 2021 of Meghmani Organochem Limited.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
21 May 2021 - Revised Investor Presentation on the Financials for the quarter and year ended 31st March, 2021 of Meghmani Finechem Limited.
Annual reports
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2013
from nse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from nse
Concalls
-
Jul 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
May 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019TranscriptNotesPPT
-
Aug 2019TranscriptNotesPPT
-
Aug 2019Transcript PPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptNotesPPT
-
Oct 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
Aug 2018TranscriptNotesPPT
-
May 2018Transcript PPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017Transcript PPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptPPT
-
Feb 2017Transcript PPT
-
Nov 2016TranscriptPPT
-
Nov 2016Transcript PPT
-
Aug 2016Transcript PPT
-
Nov 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Pigments (29% of revenue) [1]
The company is amongst the top 3 global Phthalocyanine based pigment players. 14% global market share.
3 vertically integrated Manufacturing facilities [2]
The company is trying to expand into new geographies and explore new pigments. The company has strong client relationships (90% business from repeat clients). The high degree of product customization, consistent quality, and compliance regulations add to client stickiness